Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET3 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | CCDC151 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | CCNJ | FIMM | pan-cancer | AAC | 0.61 | 0.0001 |
mRNA | ZFYVE21 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | PROM2 | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
mRNA | AHCYL2 | FIMM | pan-cancer | AAC | 0.6 | 0.0001 |
mRNA | F11R | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
mRNA | N4BP1 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | FAM104B | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |